Skip to content

Insider · CIK 0001576147

Peter Anevski

ceoofficerdirector

Files at PGNY (Progyny, Inc.). First filing Dec 26, 2024, latest Nov 17, 2025.

In brief

Peter Anevski files SEC Form 4 as CEO and director at PGNY (Progyny, Inc.). Since Dec 26, 2024, Peter Anevski has reported 2 open-market buys worth $5.0M and 0 open-market sells worth $0, the latest filed on Nov 17, 2025.

A track record needs three past buys with six months of prices behind them; Peter Anevski has 0, so none is measured yet.

The newest scored trade: bought $1.9M of PGNY on Nov 13, 2025, filed Nov 17, 2025, scored 53 (moderate). In the last 12 months: 1 buy worth $1.9M and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$5.0M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PGNY: Progyny, Inc.

PGNYOct 9, 2026 · close 27.93

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
53Moderate
PGNYbuy
Progyny, Inc.
$1.9M
79,500 shares
+13%+79% from low0% from high
68Notable
PGNYbuy 2
Progyny, Inc.
$3.0M
209,500 shares
+90%-

Transactions

Every row this insider has filed, 18 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 3, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-5,361$26.29$141k806,11135 d ago
Jun 3, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-5,361$25.12$135k811,472Jun 5, 2026
Mar 2, 2026PGNY
Progyny, Inc.
AGrant or award
Common Stock
+159,091$0.00$0834,444Mar 4, 2026
Mar 3, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-17,611$17.60$310k816,833Mar 4, 2026
Mar 2, 2026PGNY
Progyny, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+232,011$0.00$0232,011Mar 4, 2026
Jan 2, 2026PGNY
Progyny, Inc.
FTax withholding
Common Stock
-6,009$25.68$154k674,242Jan 5, 2026
Nov 13, 2025PGNY
Progyny, Inc.
POpen-market purchase
Common Stock
+79,500$24.29$1.9M680,251Nov 17, 2025
Nov 10, 2025PGNY
Progyny, Inc.
AGrant or award
Common Stock
+125,000$0.00$0664,564Nov 13, 2025
Nov 10, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-63,813$22.37$1.4M600,751Nov 13, 2025
Oct 1, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-7,977$21.52$172k539,564Oct 2, 2025
Jul 1, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-7,977$22.00$175k547,541Jul 2, 2025
Apr 1, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-7,977$22.34$178k555,518Apr 3, 2025
Mar 3, 2025PGNY
Progyny, Inc.
AGrant or award
Common Stock
+127,272$0.00$0563,495Mar 5, 2025
Mar 3, 2025PGNY
Progyny, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+174,239$0.00$0174,239Mar 5, 2025
Jan 2, 2025PGNY
Progyny, Inc.
FTax withholding
Common Stock
-6,162$17.25$106k435,301Jan 6, 2025
Dec 23, 2024PGNY
Progyny, Inc.
POpen-market purchase
Common Stock
+209,500$14.48$3.0M441,463Dec 26, 2024
Nov 20, 2023PGNY
Progyny, Inc.
AGrant or award
Common Stock
+125,000$0.00$0324,970Nov 22, 2023
Nov 20, 2023PGNY
Progyny, Inc.
FTax withholding
Common Stock
-63,813$32.20$2.1M261,157Nov 22, 2023

Questions about Peter Anevski

Answered from the filings on this page, as of the latest one.

Is Peter Anevski buying or selling?

In the last 12 months Peter Anevski reported 1 open-market buy worth $1.9M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.9M of PGNY on Nov 13, 2025. Grants, option exercises and tax withholding are not counted.

How did Peter Anevski's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Anevski has 0.

Where does Peter Anevski file Form 4?

Peter Anevski has filed Form 4 at PGNY (Progyny, Inc.) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Peter Anevski: insider trades and track record | InsiderTell